A new compound has been synthesized that suppresses the growth of cancer cells

341
2
AK&M 23 November 2026 02:38

Scientists at Tomsk Polytechnic University (TPU), together with Russian colleagues, have synthesized a previously unknown organic compound based on benzoxazole, which is able to glow and inhibit the growth of cancer cells. The new substance has successfully passed laboratory tests. The development can form the basis for the creation of new molecular tools for the diagnosis and targeted therapy of cancer.

The development of new benzoxazole derivatives is of interest to scientists, as these compounds demonstrate a variety of biological activities (antimicrobial, antiviral, and anticancer), have properties to slow down the process of cell division, and are already used in the creation of certain drugs.

Chemists from Tomsk Polytechnic University, together with colleagues from SibSMU and the A.N. Nikolaev Institute of Inorganic Chemistry of the Siberian Branch of the Russian Academy of Sciences, synthesized a previously unknown compound, 2-(3-(fluorosulfato)phenyl)benzoxazole, which has cytostatic properties against cancer cells and fluorescent characteristics, that is, the ability to glow.

"The integration of cytostatic properties with fluorescent characteristics opens up unique opportunities for using the new compound in chemical biology, molecular diagnostics and personalized medicine, for example, for real-time monitoring, potentially deepening our understanding of drug interactions with cells and contributing to the development of more effective targeted therapies," said the project leader, an employee of the laboratory of Molecular Modeling. and the synthesis of biologically active compounds of Reliable Danilenko TPU.

The benzoxazole derivatives synthesized in the work were successfully tested in vitro on prostate adenocarcinoma and breast adenocarcinoma cell lines.

"The research results have shown that the biological activity of the new compounds makes them a promising basis for the development of drugs for growth retardation and treatment of malignant neoplasms," said Evgeny Plotnikov, one of the authors of the study, associate professor at the TPU Research School of Chemical and Biomedical Technologies.

In the future, the scientists plan to conduct research aimed at studying the relationship between structure and activity, as well as the molecular mechanisms of action, which will be crucial in optimizing the compounds obtained for specific biomedical applications.

The research was supported by a grant from the Russian Science Foundation.

 

Please note that this press release is based on materials provided by the company. AK&M Information Agency shall not be held liable for its contents, nor for the legal and other consequences of its publication.